抗高血圧剤との組み合わせのCETP阻害剤及びその使用

Japanese Patent JP2005538977

A

This invention relates to pharmaceutical combinations of a cholesteryl ester transfer protein (CETP) inhibitor or a pharmaceutically acceptable salt thereof; and an antihypertensive agent or a pharmaceutically acceptable salt thereof, optionally in combination with an HMG CoA reductase inhibitor or a pharmaceutically acceptable salt thereof, kits containing such combinations and methods of using such combinations to treat subjects suffering from atherosclerosis, peripheral vascular disease, dyslipidemia, hyperbetaliproteinemia, hypoalphalipoproteinemia, hypercholesterolemia, hypertriglyceridemia, familial-hypercholesterolemia, cardiovascular disorders, angina, ischemia, cardiac ischemia, stroke, myocardial infarction, reperfusion injury, angioplastic restenosis, hypertension, vascular complications of diabetes, obesity or endotoxemia in a mammal (including a human being either male or female).

Ruggeli, Roger Benjamin

JP2004519070A

December 22, 2005

June 20, 2003

Click for automatic bibliography generation  

Pfizer Products Inc.

A61K31/00; A61K31/275; A61K31/40; A61K31/401; A61K31/403; A61K31/4178; A61K31/4422; A61K31/47; A61K31/4706; A61K31/4965; A61K31/517; A61K31/554; A61K45/06; A61P3/04; A61P3/06; A61P3/10; A61P9/00; A61P9/08; A61P9/10; A61P9/12; (IPC1-7): A61K45/06; A61K31/275; A61K31/40; A61K31/401; A61K31/403; A61K31/4178; A61K31/4422; A61K31/4706; A61K31/4965; A61K31/517; A61K31/554; A61P3/04; A61P3/06; A61P3/10; A61P9/00; A61P9/08; A61P9/10; A61P9/12

JP2001242173A	2001-09-07
JP2001206845A	2001-07-31
JP2002179558A	2002-06-26
JP2001514223A	2001-09-11
JP2002509540A	2002-03-26
JP2001288115A	2001-10-16

WO2000017165A1	2000-03-30
WO2002047678A1	2002-06-20

Atsushi Aoki
Takashi Ishida
Fukumoto product
Tetsuji Koga
Kazuhiro Nakamura
Masaya Nishiyama

Previous Patent: ベンゾプロスタサイクリン中間体、及びそれらの製造方法

Next Patent: 結晶形のイミドアルカン過カルボン酸